PAK1 and breast cancer: Given the evolutionarily conserved role of PAK1 in regulating cytoskeletal dynamics and the common use of microtubule inhibitors in later lines of breast cancer treatment, we evaluated the mechanism and potential therapeutic benefit of FRAX1036 combination with docetaxel.